Virus-Like Particle Vaccine Market Latest Report 2023-2031 | InsightAce Analytic
16 nov. 2023 02h32 HE
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Nov. 16, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Virus-Like Particle Vaccine Market- (By...
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
09 nov. 2023 16h05 HE
|
HilleVax, Inc.
BOSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Hepatitis B Vaccine (Recombinant) Market Size, Market Share, Data Analysis and Forecasts, 2023-2030 | Market Study by RationalStat
09 nov. 2023 08h00 HE
|
Rationalstat LLC
Wilmington, Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Hepatitis B Vaccine (Recombinant) Market value is estimated at US$ 6.5...
HilleVax to Present at Upcoming Investor Conferences
01 nov. 2023 16h48 HE
|
HilleVax, Inc.
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference
31 oct. 2023 08h00 HE
|
Icosavax, Inc.
SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda
19 oct. 2023 09h16 HE
|
Sabin Vaccine Institute
WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers...
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
17 oct. 2023 07h00 HE
|
AC Immune SA
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference Lausanne, Switzerland, October 17, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...
Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections
05 oct. 2023 09h00 HE
|
Exbaq LLC
Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and FungiVaccine provides protection against infections within 24hours and protection lasts for up to...
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
26 sept. 2023 16h01 HE
|
HilleVax, Inc.
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Paediatric Vaccine Market Projections: Surging at a Striking 13.1% CAGR, Anticipating US$ 184,706.7 Million Valuation by 2033 | Future Market Insights, Inc.
25 sept. 2023 13h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del:, Sept. 25, 2023 (GLOBE NEWSWIRE) -- In 2023, the paediatric vaccine market is expected to be worth US$ 54,130.1 million. The market is expected to grow at a remarkable 13.1% CAGR to a...